The bill improves EMS supply resilience, care coordination, and oversight—helping Medicare beneficiaries and rural communities avoid dangerous shortages—but does so at the cost of higher Medicare/taxpayer spending, multi‑year funding commitments, and added administrative burdens that may strain small and rural EMS providers.
Medicare beneficiaries and other emergency patients — especially in rural and underserved communities — will face fewer life‑threatening EMS supply shortages because EMS agencies receive predictable supplemental payments to stock critical medications, blood products, and necessary supplies.
Participating EMS agencies and affiliated hospitals receive regular lump‑sum payments that reduce financial volatility for ambulance providers and help cover acquisition, storage, and administrative costs.
The program requires standardized data collection and a post‑model report analyzing morbidity, mortality, utilization, and equity, generating evidence to inform future EMS policy and improve supply resilience and equity.
Taxpayers and Medicare are likely to see higher spending because the bill creates new supplemental payments to EMS agencies and could lead to additional MedPAC‑recommended payment expansions.
Basing payments on service area supply needs rather than actual Medicare administrations could overcompensate agencies and fund non‑Medicare care, increasing program costs without a direct link to Medicare utilization.
Smaller and rural EMS agencies (and some hospitals) may face significant administrative and technical burdens — meeting reporting requirements (NEMSIS, ICD‑10, outcomes), investing in software/data integration, and complying with new rules — to qualify for payments.
Based on analysis of 3 sections of legislative text.
Creates a five‑year Medicare demonstration to pay EMS agencies supplemental lump sums for lifesaving medications and blood products and directs MedPAC to study EMS payment and medical director roles.
Introduced May 15, 2025 by Richard Hudson · Last progress May 15, 2025
Creates a Medicare demonstration to provide supplemental lump‑sum payments to participating ground and air EMS agencies to cover costs of keeping on hand specified life‑saving medications and blood products that must be given immediately to patients with emergency medical conditions. The Health and Human Services Secretary must select at least one eligible entity per HHS region (and, where feasible, a mix of EMS agency types), set payment rates based on agencies’ total costs (including accelerated initial medication acquisition), run the model for at least five years, and report to Congress on utilization and outcomes after the model ends. Also directs the Medicare Payment Advisory Commission (MedPAC) to deliver a report within two years that evaluates current Medicare payment for EMS, examines the role and reimbursement of EMS physician medical directors (including whether separate payment for medical direction is justified), assesses how EMS modernization affects supervision needs, and issues recommendations for payment models and quality oversight.